Editor’s note: This story has been updated with additional information on Pear’s financial state.
The assets of prescription digital therapeutics maker Pear Therapeutics have been broken up and sold at auction for $6.05 million after the company filed for bankruptcy in April.
According to the court filing, Pear’s assets were split between four bidders: Digital therapeutics company Click Therapeutics, Harvest BIO, sleep tech company Nox Health Group and health technology company Welt.
The largest bid of the group came from Nox Health, which will obtain Pear’s assets related to Somryst, a prescription digital therapeutic that uses cognitive behavioral therapy for insomnia to train the brain and body to sleep. Nox will pay $3.9 million for the assets.